In silico describes experiments run in computer models rather than in living organisms or physical laboratories, such as AI‑driven simulations of drug behaviour or trial outcomes. This term matters because in‑silico results can greatly speed research but do not replace in vitro or in vivo evidence, and misunderstandings here can lead to overestimating readiness for clinical deployment.